Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Clinical trials have found that people who are on the prescription for a year can lose more than 10% of their body weight.

Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and consumption in a small trial involving peopl

The new findings add to growing evidence that the medicines could help people with alcohol addiction. View on euronews

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.